Oncimmune Holdings plc (LON:ONC – Get Free Report)’s stock price dropped 4.2% during trading on Monday . The stock traded as low as GBX 14.85 ($0.19) and last traded at GBX 14.85 ($0.19). Approximately 210,591 shares changed hands during trading, an increase of 72% from the average daily volume of 122,679 shares. The stock had previously closed at GBX 15.50 ($0.20).
Oncimmune Stock Down 4.2 %
The company has a current ratio of 1.13, a quick ratio of 0.63 and a debt-to-equity ratio of 806.85. The firm has a market capitalization of £11.01 million, a price-to-earnings ratio of -495.00 and a beta of 1.19. The firm has a 50 day moving average price of GBX 16.76 and a two-hundred day moving average price of GBX 16.33.
Oncimmune Company Profile
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Featured Articles
- Five stocks we like better than Oncimmune
- Overbought Stocks Explained: Should You Trade Them?
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Applied Materials Market Capitulates: Now is the Time to Buy
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
